Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Clinical Study to Assess the Impact of Symbicort® pMDI Medication Reminders on Adherence in COPD Patients

NCT02864342 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT02864342
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02864342 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Clinical Study to Assess the Impact of Symbicort® pMDI Medication Reminders on Adherence in COPD Patients
Lead sponsor
AstraZeneca
Phase
Phase 4
Overall status
Completed
Start date
August 12, 2016
Completion date
October 31, 2017
Enrollment
138 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

chronic obstructive pulmonary disease (copd